We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.45B
AUM Growth
+$159M
Cap. Flow
+$157M
Cap. Flow %
4.56%
Top 10 Hldgs %
19.57%
Holding
138
New
6
Increased
106
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$25.7M
2
HAE icon
Haemonetics
HAE
+$21.4M
3
WSC icon
WillScot Mobile Mini Holdings
WSC
+$20.9M
4
KBR icon
KBR
KBR
+$16.1M
5
HURN icon
Huron Consulting
HURN
+$13.4M

Sector Composition

Rank Sector Weight
1 Industrials 20.68%
2 Healthcare 17.35%
3 Technology 15.95%
4 Financials 12.7%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGI icon
51
Alamos Gold
AGI
$12B
$28M 0.81%
3,178,065
+158,164
+5% +$1.59M
BWIN
52
Baldwin Insurance Group
BWIN
$2.79B
$26.6M 0.77%
1,067,003
+213,331
+25% +$4.62M
MATW icon
53
Matthews International
MATW
$880M
$26.4M 0.76%
1,179,688
+47,079
+4% +$1.01M
WAB icon
54
Wabtec
WAB
$50.5B
$26.4M 0.76%
426,093
+12,257
+3% +$786K
UTL icon
55
Unitil
UTL
$964M
$24.8M 0.72%
641,735
+8,002
+1% +$336K
FCN icon
56
FTI Consulting
FCN
$4.34B
$24.5M 0.71%
231,644
+19,314
+9% +$2.19M
CALM icon
57
Cal-Maine
CALM
$3.98B
$24.2M 0.7%
630,394
+246,225
+64% +$10.4M
HQY icon
58
HealthEquity
HQY
$8.78B
$24.1M 0.7%
+468,666
New +$25.7M
WWE
59
DELISTED
World Wrestling Entertainment
WWE
$24M 0.69%
592,616
+22,696
+4% +$995K
IT icon
60
Gartner
IT
$12.4B
$23.2M 0.67%
185,606
+44,108
+31% +$5.61M
CMCO icon
61
Columbus McKinnon
CMCO
$622M
$22.7M 0.66%
687,122
+7,720
+1% +$268K
TCF
62
DELISTED
TCF Financial Corporation Common Stock
TCF
$22.5M 0.65%
962,731
+39,870
+4% +$1.07M
SUPN icon
63
Supernus Pharmaceuticals
SUPN
$2.51B
$22.4M 0.65%
1,072,452
+44,614
+4% +$1.01M
WSC icon
64
WillScot Mobile Mini Holdings
WSC
$4.83B
$21.8M 0.63%
+1,308,779
New +$20.9M
IWN icon
65
iShares Russell 2000 Value ETF
IWN
$14.7B
$21.5M 0.62%
216,752
-9,599
-4% -$975K
HAE icon
66
Haemonetics
HAE
$3.88B
$21.3M 0.62%
+244,309
New +$21.4M
MD icon
67
Pediatrix Medical
MD
$2.03B
$21M 0.61%
1,286,936
+52,553
+4% +$978K
CAMP
68
DELISTED
CalAmp Corp.
CAMP
$20.7M 0.6%
125,271
+4,669
+4% +$875K
CNS icon
69
Cohen & Steers
CNS
$4.32B
$20.3M 0.59%
364,217
+20,973
+6% +$1.29M
NDAQ icon
70
Nasdaq
NDAQ
$52.3B
$19.8M 0.57%
484,140
-80,052
-14% -$3.41M
IEX icon
71
IDEX
IEX
$17.5B
$19.7M 0.57%
107,734
-11,691
-10% -$2.02M
WWW icon
72
Wolverine World Wide
WWW
$1.59B
$19M 0.55%
734,580
+61,871
+9% +$1.51M
SP
73
DELISTED
SP Plus Corporation
SP
$19M 0.55%
1,056,292
+11,413
+1% +$210K
AZZ icon
74
AZZ Inc
AZZ
$4.59B
$18.9M 0.55%
552,574
+31,316
+6% +$1.04M
ATR icon
75
AptarGroup
ATR
$8.66B
$18.3M 0.53%
161,779
+3,954
+3% +$463K

Similar funds

Aristotle Capital Boston's Q3 2020 Portfolio in Review

As of Q3 2020, Aristotle Capital Boston held 138 positions worth $3.45B, up 4.8% from $3.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston deployed $157M of net new capital in Q3 2020, opening 6 new positions and adding to 106 existing holdings. Its largest new stake was HealthEquity: 468,666 shares worth $24.1M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was 1-800-Flowers.com, an estimated $25.4M trimmed.

  • Aristotle Capital Boston's largest Q3 2020 buy was HealthEquity: 468,666 shares worth $24.1M.
  • Aristotle Capital Boston added most to Huron Consulting in Q3 2020, an estimated $13.4M increase.
  • Aristotle Capital Boston's biggest Q3 2020 reduction was 1-800-Flowers.com, cutting an estimated $25.4M.
  • Aristotle Capital Boston fully exited Noble Energy, Inc. in Q3 2020, selling an estimated $4.15M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $3.45B portfolio in Q3 2020.
  • Aristotle Capital Boston opened 6 new positions and closed 1 in Q3 2020.
  • Aristotle Capital Boston's portfolio value rose 4.8% quarter-over-quarter to $3.45B.

Based on Aristotle Capital Boston's 13F filing for Q3 2020, filed 16 Nov 2020.